(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NEUROTROPIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

NEUROTROPIN

ST13

US500000075627101

Class

5

Filing

75627101

Registration

2392807

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

10/29/2020

Trademark type

Word

Nice classes

5

Filing date

01/25/1999

Registration date

10/10/2000

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/29/2020

Last transaction

10/29/2020

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

Drawing code

1

Owner type

03

Owner location

Osaka-shi, Osaka-fu, JP

Examiner

WOLDOW,SCOTT

Law office

L50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Nippon Zoki Pharmaceutical Co., Ltd.
Nippon Zoki Pharmaceutical Co., Ltd.

Representatives

Holly M. Ford Lewis Oliff PLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparation for use in the treatment of painneuralgiapruritusallergic diseasesinflammationrhinitisarthritisperipheral circulatory disturbancecoldnessdysesthesianeuropathyreflex sympathetic dystrophyedemadementiavirus diseasedistress syndromeimmunodeficiency syndromeautoimmume diseasesautonomic dystoniaspiro-cerebellar degeneration or thrombocylopenia

Publications

History of USPTO decisions and trademark events.

23 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

10/29/2020

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

10/29/2020

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/29/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/29/2020

E89R

TEAS SECTION 8 & 9 RECEIVED

09/11/2020

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

10/10/2019

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

08/25/2010

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

08/25/2010

E89R

TEAS SECTION 8 & 9 RECEIVED

08/12/2010

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/22/2008

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/22/2008

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

09/29/2006

PLGL

ASSIGNED TO PARALEGAL

09/19/2006

8.AF

REGISTERED - SEC. 8 (6-YR) FILED

07/07/2006

MAIL

PAPER RECEIVED

07/07/2006

CFIT

CASE FILE IN TICRS

02/07/2006

R.PR

REGISTERED-PRINCIPAL REGISTER

10/10/2000

PUBO

PUBLISHED FOR OPPOSITION

07/18/2000

NPUB

NOTICE OF PUBLICATION

06/16/2000

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/12/2000

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/19/2000

CNRT

NON-FINAL ACTION MAILED

07/21/1999

DOCK

ASSIGNED TO EXAMINER

07/12/1999

Continuous trademark protection

Get notified about every new filing that threatens NEUROTROPIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.